» Articles » PMID: 18828023

Immunoscreening of Urinary Bladder Cancer CDNA Library and Identification of Potential Tumor Antigen

Overview
Journal World J Urol
Specialty Urology
Date 2008 Oct 2
PMID 18828023
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To identify potential tumor antigen by immunoscreening the urinary bladder cancer cDNA library with monoclonal antibodies.

Methods: Monoclonal antibodies were prepared. A cDNA expression library was constructed from bladder cancer cell line BLZ211. Immunogenic proteins were identified by immunoscreening the cDNA library with ten monoclonal antibodies.

Results: The cDNA library of BLZ211 cells was established using lambdaZAP as vector. The titer of unamplified cDNA library was 1.39x10(6) pfu/ml with a recombinant rate of 97.72%, and titer of amplified one was 8.4x10(9) pfu/ml. After immunoscreening, ten positive clones representing ten different antigens were identified, which include two proteins with unknown function; coactosin-like 1, eukaryotic translation elongation factor, HNRPA1, histidine triad nucleotide binding protein, KRT7, LCN2, TSTA3, zinc finger protein, C11orf48 and HSPC148.

Conclusion: The cDNA library was of high quality and can be used in further study. By immunoscreening the bladder cancer cDNA library with ten monoclonal antibodies, we identified ten immunogenic proteins that otherwise would not have been identified as potential diagnostic marker and vaccinogens of bladder cancer using the gene discovery effort.

Citing Articles

Study of LBHD1 Expression with Invasion and Migration of Bladder Cancer.

Dong C, Liu Y, Yu G, Li X, Chen L Open Life Sci. 2021; 14:440-447.

PMID: 33817179 PMC: 7874779. DOI: 10.1515/biol-2019-0049.


Non-translational Connections of eEF1B in the Cytoplasm and Nucleus of Cancer Cells.

Negrutskii B Front Mol Biosci. 2020; 7:56.

PMID: 32328499 PMC: 7160314. DOI: 10.3389/fmolb.2020.00056.


Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.

Guo S, Yang P, Jiang X, Li X, Wang Y, Zhang X Oncotarget. 2016; 8(1):644-657.

PMID: 27893417 PMC: 5352185. DOI: 10.18632/oncotarget.13501.


Independent overexpression of the subunits of translation elongation factor complex eEF1H in human lung cancer.

Veremieva M, Kapustian L, Khoruzhenko A, Zakharychev V, Negrutskii B, Elskaya A BMC Cancer. 2014; 14:913.

PMID: 25472873 PMC: 4265501. DOI: 10.1186/1471-2407-14-913.


Hsp74, a potential bladder cancer marker, has direct interaction with keratin 1.

Chen L, Wang Y, Zhao L, Chen W, Dong C, Zhao X J Immunol Res. 2014; 2014:492849.

PMID: 25050384 PMC: 4094855. DOI: 10.1155/2014/492849.


References
1.
Landis S, Murray T, Bolden S, Wingo P . Cancer statistics, 1998. CA Cancer J Clin. 1998; 48(1):6-29. DOI: 10.3322/canjclin.48.1.6. View

2.
Okayama H, Berg P . High-efficiency cloning of full-length cDNA. Mol Cell Biol. 1982; 2(2):161-70. PMC: 369769. DOI: 10.1128/mcb.2.2.161-170.1982. View

3.
van Rhijn B, van der Poel H, van der Kwast T . Urine markers for bladder cancer surveillance: a systematic review. Eur Urol. 2005; 47(6):736-48. DOI: 10.1016/j.eururo.2005.03.014. View

4.
Friedl A, Stoesz S, Buckley P, Gould M . Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J. 1999; 31(7):433-41. DOI: 10.1023/a:1003708808934. View

5.
Nguyen C, Stephen Jones J . Defining the role of NMP22 in bladder cancer surveillance. World J Urol. 2007; 26(1):51-8. DOI: 10.1007/s00345-007-0226-z. View